2025-05-24 - Analysis Report
Okay, here's the report on Eli Lilly and Co (LLY), incorporating the provided data and analysis requests:

## Eli Lilly and Co (LLY) Stock Analysis

**Ticker:** LLY
**Company Name:** Eli Lilly and Co
**Description:** Eli Lilly and Co. is a global pharmaceutical company that discovers, develops, manufactures, and markets pharmaceutical products.

### 1. Performance vs. S&P 500 (VOO)

*   **LLY Cumulative Return:** 241.06%
*   **VOO Cumulative Return:** 79.45%
*   **Absolute Spread:** 161.6 (LLY outperformed VOO by this amount)
*   **Relative Spread Position:** 55.5 (This indicates that LLY's outperformance is in the upper-middle range of its historical spread against VOO.)
    *   Range (Max: 313.1, Min: -27.6)

**Alpha/Beta Analysis Table:**

| Year       | CAGR  | MDD   | Alpha | Beta | Cap(B) |
|------------|-------|-------|-------|------|--------|
| 2015-2017  | 10.0% | 56.3% | -19.0% | 0.1  | 67.5   |
| 2016-2018  | 38.0% | 58.6% | 20.0%  | -0.1 | 94.9   |
| 2017-2019  | 49.0% | 58.6% | 19.0%  | 0.3  | 110.2  |
| 2018-2020  | 51.0% | 58.6% | 25.0%  | 0.1  | 144.4  |
| 2019-2021  | 105.0%| 60.6% | 50.0%  | 0.3  | 239.8  |
| 2020-2022  | 100.0%| 65.0% | 94.0%  | 0.3  | 321.9  |
| 2021-2023  | 139.0%| 65.0% | 122.0% | 0.3  | 518.0  |
| 2022-2024  | 156.0%| 72.2% | 139.0% | 0.3  | 690.4  |
| 2023-2025  | 91.0% | 76.8% | 64.0%  | 0.2  | 640.7  |

**Analysis:**

*   LLY has significantly outperformed the S&P 500 (VOO) as reflected in the cumulative return difference. The positive spread indicates LLY has generated substantially higher returns.
*   The Relative Spread Position suggests that while LLY's outperformance is strong, there have been periods of even greater outperformance in the past.
*   The Alpha/Beta analysis highlights LLY's historical performance relative to the market.  Positive Alpha values indicate outperformance on a risk-adjusted basis.  Beta values are generally low, suggesting that LLY's price movements are not strongly correlated with the overall market.
*   CAGR has been strong, especially in more recent periods.
*   Maximum Drawdown (MDD) has increased, which may reflect higher volatility or market corrections.
*   The company's capitalization has grown significantly over the years, reflecting its growth and increasing market value.

### 2. Recent Price Action

*   **Current Price:** \$713.71
*   **Last Day's Change:** -0.21 (Slight decrease)
*   **5-Day Moving Average:** \$731.20
*   **20-Day Moving Average:** \$773.98
*   **60-Day Moving Average:** \$804.48

**Analysis:**

*   The current price is below all three moving averages (5, 20, and 60 day).  This suggests a short-term downtrend.
*   The price drop from the previous close, while small, confirms the recent downward movement.
*   The fact that the 5-day moving average is below the 20-day, and the 20-day below the 60-day, reinforces the indication of a downtrend.

### 3. Technical Indicators

*   **Market Risk Indicator (MRI):** 0.3656 (Low Risk)
*   **RSI:** 27.69 (Oversold)
*   **PPO:** -0.6644
*   **Recent (20-day) Relative Spread Change:** -0.4 (Short-term decrease)
*   **Expected Return (%):** 124.2%

**Analysis:**

*   The MRI indicates a low-risk environment for the stock, suggesting stability compared to the broader market.
*   The RSI value indicates that LLY is currently in oversold territory, which could suggest a potential buying opportunity, although it's important to consider other indicators.
*   The negative PPO value suggests that the short-term moving average is below the long-term moving average, confirming the downtrend indicated by the moving averages.
*   The negative change in the relative spread over the past 20 days suggests that LLY's outperformance relative to VOO has decreased recently.
*   The significant Expected Return suggests strong long-term growth potential, but this should be viewed as an estimate and not a guarantee.
*   The slight price decrease from {'price': 713.71, 'previousClose': 715.2, 'change': -0.21} is a small value and doesn't signal a significant volatility event in itself.

### 4. Recent News & Significant Events

*   **2025-05-22:** Major business developments, regulatory changes, or market events.
*   **2025-05-21:** Analyst discussions on LLY's performance and outlook.
*   **2025-05-23:** Notable stock volatility influenced by recent news, earnings reports, or executive actions.
*   **2025-05-24:** Market experts highlight both risks and opportunities for LLY.

**Analysis:**

*   Recent news indicates that LLY is experiencing volatility and is subject to analyst scrutiny.  This could be due to a number of factors, including earnings announcements, regulatory changes, or new product developments.
*   It's crucial to investigate the specific news items mentioned in these summaries to understand the drivers behind the volatility and analyst opinions.

### 5. Recent Earnings Analysis

| 날짜       | EPS  | 매출        |
|------------|------|-------------|
| 2025-05-01 | 3.07 | 12.73 B\$  |
| 2024-10-30 | 1.08 | 11.44 B\$  |
| 2024-08-08 | 3.29 | 11.30 B\$  |
| 2024-04-30 | 2.49 | 8.77 B\$   |
| 2025-05-01 | 2.49 | 8.77 B\$   |

**Analysis:**

*   Overall, the revenues show an increasing trend.
*   Earnings per Share (EPS) were high in 2025-05-01 and 2024-08-08, but relatively lower in 2024-10-30, showing volatility in profitability.
*   It is important to note that the first and last rows have the same date (2025-05-01) and values. This might be an error and should be verified.

### 6. Financial Information

**Revenue and Profitability:**

| Quarter    | Revenue   | Profit Margin |
|------------|-----------|---------------|
| 2025-03-31 | \$12.73B  | 82.53%        |
| 2024-12-31 | \$13.53B  | 82.24%        |
| 2024-09-30 | \$11.44B  | 81.02%        |
| 2024-06-30 | \$11.30B  | 80.80%        |
| 2024-03-31 | \$8.77B   | 80.91%        |

**Capital and Profitability:**

| Quarter    | Equity    | ROE      |
|------------|-----------|----------|
| 2025-03-31 | \$15.76B  | 17.50%   |
| 2024-12-31 | \$14.19B  | 31.07%   |
| 2024-09-30 | \$14.24B  | 6.81%    |
| 2024-06-30 | \$13.56B  | 21.88%   |
| 2024-03-31 | \$12.81B  | 17.51%   |

**Analysis:**

*   **Revenue and Profitability:** Revenue generally shows an increasing trend, indicating healthy growth. Profit margins are consistently high, suggesting efficient operations and strong pricing power.
*   **Capital and Profitability:** Equity has been increasing, indicating a growing asset base. Return on Equity (ROE) has been fluctuating, with a notable peak in Q4 2024.

### 7. Overall Analysis

Eli Lilly and Co. (LLY) has demonstrated strong historical outperformance compared to the S&P 500, as evidenced by its high cumulative return and positive Alpha. Financial performance is robust, with increasing revenues and high profit margins. However, the stock is currently experiencing a short-term downtrend, as indicated by its price action and technical indicators (RSI in oversold territory, negative PPO). Recent news suggests that the stock is subject to volatility and market scrutiny.

**Investment Considerations:**

*   **Strengths:** Strong historical performance, robust financial results (high profit margins and rising revenue), positive long-term expected return, and a low Market Risk Indicator.
*   **Weaknesses/Risks:** Recent short-term downtrend, high MDD, volatility due to recent news, and potential regulatory or market changes.
*   **Recommendation:** Given the strong fundamentals and high long-term expected return, LLY may be a suitable candidate for long-term investment, especially when taking advantage of the dip. However, investors should carefully monitor recent news, analyst ratings, and the stock's price action to manage risk. The oversold RSI suggests a potential buying opportunity, but confirmation with other indicators is warranted.

